Lymphoma in Dogs: Treatment Options and Quality of Life Decisions

Lymphoma is one of the most common cancers in dogs, accounting for 7–24% of all canine tumours. It is also one of the most treatment-responsive, making honest prognosis discussions and quality-of-life planning essential.

Key Facts

Canine lymphoma most commonly presents as multicentric lymphoma with painless lymph node enlargement throughout the body
Golden Retrievers, Boxers, Bulldogs, Basset Hounds, and Saint Bernards have elevated breed predispositions
Most dogs with lymphoma are middle-aged to older (median 6–9 years at diagnosis)
Without treatment, median survival is approximately 4–6 weeks from diagnosis
With CHOP-based multi-agent chemotherapy, approximately 80–90% of dogs achieve remission with median survival of 12–14 months
Single-agent prednisone provides palliative control for 1–2 months and is appropriate when chemotherapy is declined
T-cell lymphoma carries a significantly worse prognosis than B-cell lymphoma; immunophenotyping helps guide treatment decisions
Quality of life during CHOP chemotherapy is generally good — side effects are managed and dogs often feel well between treatments

Welfare Considerations

Lymphoma welfare decisions require balancing the genuine survival benefits of treatment against treatment burden and cost. Dogs generally tolerate CHOP chemotherapy well — veterinary oncologists manage side effects proactively and dogs typically maintain good quality of life between cycles. However, remission is temporary and relapse is expected. When lymphoma relapses, second-line protocols have lower response rates and shorter remission times. The decision to pursue rescue chemotherapy versus palliative care requires honest assessment of the individual dog's quality of life. Dogs in remission often appear and behave normally; dogs with relapsed, uncontrolled disease may deteriorate rapidly. Early quality-of-life conversations ensure that decisions are made based on the dog's experience rather than owner hope alone.

What You Can Do

Seek prompt veterinary assessment for any dog with rapidly enlarging lymph nodes, even if the dog seems well
Request immunophenotyping (B vs. T cell) as this significantly affects prognosis and treatment planning
Discuss quality-of-life expectations honestly with a board-certified veterinary oncologist before committing to treatment
Use a quality-of-life scale to track your dog's wellbeing throughout treatment
Consider pet insurance for predisposed breeds to ensure financial barriers do not limit access to treatment options